Pharmacogenomics Market

Pharmacogenomics Market - Global Industry Assessment & Forecast

Healthcare

# Pages:

198

Base Year:

2023

Apr - 2024

Format:

Report Code:

VMR-2452

Segments Covered

By Product & Service Kits & Reagent, Service
By Technology Sequencing, PCR, Microarray, Other Technologies
By Application Personalized Medicine, Clinical Research, Drug Discovery & Preclinical Development
By Disease Area Cancer, Cardiovascular, Neurological Diseases, Other Disease Areas
By End User Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Contract Research Organizations
By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Standard License

$ 4299 USD

Multi User License

$ 6599 USD

Enterprise License

$ 6999 USD

Snapshot

Base Year:	2023
Forecast Years:	2024 - 2032
Historical Years:	2018 - 2022
Revenue 2023:	USD 3.35 Billion
Revenue 2032:	USD 8.11 Billion
Revenue CAGR (2024 - 2032):	10.3%
Fastest Growing Region (2024 - 2032)	Asia Pacific
Largest Region (2023):	North America

Customization Offered

Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market Dynamics
Region Level Market Share
Import Export Analysis
Production Analysis
Others Request Customization Speak To Analyst

Executive Dashboard
1. Strategic Imperatives
Premium Insights
1. Top 3 Trends to Watch
2. Demand and Supply Trends
3. Top 3 Strategies Followed by Major Players
4. Top 3 Predictions by Vantage Market Research
5. Top Investment Pockets
6. Insights from Primary Respondents
Global Pharmacogenomics Market - Segment Analysis
1. Overview
2. Global Pharmacogenomics Market, 2016 - 2028 (USD Million)
3. Global Pharmacogenomics Market - by Product & Service
  1. By Kits & Reagent
  2. By Service
4. Global Pharmacogenomics Market - by Technology
  1. By Sequencing
  2. By PCR
  3. By Microarray
  4. By Other Technologies
5. Global Pharmacogenomics Market - by Application
  1. By Personalized Medicine
  2. By Clinical Research
  3. By Drug Discovery & Preclinical Development
6. Global Pharmacogenomics Market - by Disease Area
  1. By Cancer
  2. By Cardiovascular
  3. By Neurological Diseases
  4. By Other Disease Areas
7. Global Pharmacogenomics Market - by End User
  1. By Academic & Research Institutes
  2. By Pharmaceutical & Biotechnology Companies
  3. By Contract Research Organizations
8. Global Pharmacogenomics Market - by region
  1. North America
  2. Europe
  3. Asia Pacific
  4. Latin America
  5. Middle East & Africa
9. Market comparative analysis
North America Pharmacogenomics Market - Segment Analysis
1. Overview
2. North America Pharmacogenomics Market, 2016 - 2028 (USD Million)
3. North America Pharmacogenomics Market, by Product & Service
  1. By Kits & Reagent
  2. By Service
4. North America Pharmacogenomics Market, by Technology
  1. By Sequencing
  2. By PCR
  3. By Microarray
  4. By Other Technologies
5. North America Pharmacogenomics Market, by Application
  1. By Personalized Medicine
  2. By Clinical Research
  3. By Drug Discovery & Preclinical Development
6. North America Pharmacogenomics Market, by Disease Area
  1. By Cancer
  2. By Cardiovascular
  3. By Neurological Diseases
  4. By Other Disease Areas
7. North America Pharmacogenomics Market, by End User
  1. By Academic & Research Institutes
  2. By Pharmaceutical & Biotechnology Companies
  3. By Contract Research Organizations
8. North America Pharmacogenomics Market, by Country
  1. U.S.
    1. U.S. Pharmacogenomics Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. U.S. Pharmacogenomics Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. U.S. Pharmacogenomics Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. U.S. Pharmacogenomics Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. U.S. Pharmacogenomics Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
  2. Canada
    1. Canada Pharmacogenomics Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. Canada Pharmacogenomics Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. Canada Pharmacogenomics Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. Canada Pharmacogenomics Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. Canada Pharmacogenomics Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
  3. Mexico
    1. Mexico Pharmacogenomics Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. Mexico Pharmacogenomics Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. Mexico Pharmacogenomics Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. Mexico Pharmacogenomics Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. Mexico Pharmacogenomics Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
Europe Pharmacogenomics Market - Segment Analysis
1. Overview
2. Europe Pharmacogenomics Market, 2016 - 2028 (USD Million)
3. Europe Pharmacogenomics Market, by Product & Service
  1. By Kits & Reagent
  2. By Service
4. Europe Pharmacogenomics Market, by Technology
  1. By Sequencing
  2. By PCR
  3. By Microarray
  4. By Other Technologies
5. Europe Pharmacogenomics Market, by Application
  1. By Personalized Medicine
  2. By Clinical Research
  3. By Drug Discovery & Preclinical Development
6. Europe Pharmacogenomics Market, by Disease Area
  1. By Cancer
  2. By Cardiovascular
  3. By Neurological Diseases
  4. By Other Disease Areas
7. Europe Pharmacogenomics Market, by End User
  1. By Academic & Research Institutes
  2. By Pharmaceutical & Biotechnology Companies
  3. By Contract Research Organizations
8. Europe Pharmacogenomics Market, by Country
  1. Germany
    1. Germany Pharmacogenomics Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. Germany Pharmacogenomics Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. Germany Pharmacogenomics Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. Germany Pharmacogenomics Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. Germany Pharmacogenomics Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
  2. UK
    1. UK Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. UK Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. UK Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. UK Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. UK Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
  3. France
    1. France Pharmacogenomics Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. France Pharmacogenomics Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. France Pharmacogenomics Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. France Pharmacogenomics Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. France Pharmacogenomics Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
  4. Spain
    1. Spain Pharmacogenomics Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. Spain Pharmacogenomics Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. Spain Pharmacogenomics Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. Spain Pharmacogenomics Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. Spain Pharmacogenomics Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
  5. Italy
    1. Italy Pharmacogenomics Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. Italy Pharmacogenomics Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. Italy Pharmacogenomics Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. Italy Pharmacogenomics Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. Italy Pharmacogenomics Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
  6. BENELUX
    1. BENELUX Pharmacogenomics Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. BENELUX Pharmacogenomics Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. BENELUX Pharmacogenomics Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. BENELUX Pharmacogenomics Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. BENELUX Pharmacogenomics Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
  7. Rest of Europe
    1. Rest Of Europe Pharmacogenomics Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. Rest Of Europe Pharmacogenomics Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. Rest Of Europe Pharmacogenomics Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. Rest Of Europe Pharmacogenomics Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. Rest Of Europe Pharmacogenomics Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
Asia Pacific Pharmacogenomics Market - Segment Analysis
1. Overview
2. Asia Pacific Pharmacogenomics Market, 2016 - 2028 (USD Million)
3. Asia Pacific Pharmacogenomics Market, by Product & Service
  1. By Kits & Reagent
  2. By Service
4. Asia Pacific Pharmacogenomics Market, by Technology
  1. By Sequencing
  2. By PCR
  3. By Microarray
  4. By Other Technologies
5. Asia Pacific Pharmacogenomics Market, by Application
  1. By Personalized Medicine
  2. By Clinical Research
  3. By Drug Discovery & Preclinical Development
6. Asia Pacific Pharmacogenomics Market, by Disease Area
  1. By Cancer
  2. By Cardiovascular
  3. By Neurological Diseases
  4. By Other Disease Areas
7. Asia Pacific Pharmacogenomics Market, by End User
  1. By Academic & Research Institutes
  2. By Pharmaceutical & Biotechnology Companies
  3. By Contract Research Organizations
8. Asia Pacific Pharmacogenomics Market, by Country
  1. China
    1. China Pharmacogenomics Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. China Pharmacogenomics Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. China Pharmacogenomics Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. China Pharmacogenomics Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. China Pharmacogenomics Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
  2. Japan
    1. Japan Pharmacogenomics Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. Japan Pharmacogenomics Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. Japan Pharmacogenomics Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. Japan Pharmacogenomics Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. Japan Pharmacogenomics Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
  3. India
    1. India Pharmacogenomics Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. India Pharmacogenomics Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. India Pharmacogenomics Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. India Pharmacogenomics Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. India Pharmacogenomics Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
  4. South Korea
    1. South Korea Pharmacogenomics Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. South Korea Pharmacogenomics Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. South Korea Pharmacogenomics Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. South Korea Pharmacogenomics Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. South Korea Pharmacogenomics Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
  5. South East Asia
    1. South East Asia Pharmacogenomics Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. South East Asia Pharmacogenomics Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. South East Asia Pharmacogenomics Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. South East Asia Pharmacogenomics Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. South East Asia Pharmacogenomics Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
  6. Rest of Asia Pacific
    1. Rest of Asia Pacific Pharmacogenomics Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. Rest of Asia Pacific Pharmacogenomics Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. Rest of Asia Pacific Pharmacogenomics Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. Rest of Asia Pacific Pharmacogenomics Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. Rest of Asia Pacific Pharmacogenomics Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
Latin America Pharmacogenomics Market - Segment Analysis
1. Overview
2. Latin America Pharmacogenomics Market, 2016 - 2028 (USD Million)
3. Latin America Pharmacogenomics Market, by Product & Service
  1. By Kits & Reagent
  2. By Service
4. Latin America Pharmacogenomics Market, by Technology
  1. By Sequencing
  2. By PCR
  3. By Microarray
  4. By Other Technologies
5. Latin America Pharmacogenomics Market, by Application
  1. By Personalized Medicine
  2. By Clinical Research
  3. By Drug Discovery & Preclinical Development
6. Latin America Pharmacogenomics Market, by Disease Area
  1. By Cancer
  2. By Cardiovascular
  3. By Neurological Diseases
  4. By Other Disease Areas
7. Latin America Pharmacogenomics Market, by End User
  1. By Academic & Research Institutes
  2. By Pharmaceutical & Biotechnology Companies
  3. By Contract Research Organizations
8. Latin America Pharmacogenomics Market, by Country
  1. Brazil
    1. Brazil Pharmacogenomics Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. Brazil Pharmacogenomics Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. Brazil Pharmacogenomics Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. Brazil Pharmacogenomics Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. Brazil Pharmacogenomics Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
  2. Argentina
    1. Argentina Pharmacogenomics Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. Argentina Pharmacogenomics Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. Argentina Pharmacogenomics Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. Argentina Pharmacogenomics Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. Argentina Pharmacogenomics Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
  3. Rest of Latin America
    1. Rest of Latin America Pharmacogenomics Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. Rest of Latin America Pharmacogenomics Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. Rest of Latin America Pharmacogenomics Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. Rest of Latin America Pharmacogenomics Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. Rest of Latin America Pharmacogenomics Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
Middle East & Africa Pharmacogenomics Market - Segment Analysis
1. Overview
2. Middle East & Africa Pharmacogenomics Market, 2016 - 2028 (USD Million)
3. Middle East & Africa Pharmacogenomics Market, by Product & Service
  1. By Kits & Reagent
  2. By Service
4. Middle East & Africa Pharmacogenomics Market, by Technology
  1. By Sequencing
  2. By PCR
  3. By Microarray
  4. By Other Technologies
5. Middle East & Africa Pharmacogenomics Market, by Application
  1. By Personalized Medicine
  2. By Clinical Research
  3. By Drug Discovery & Preclinical Development
6. Middle East & Africa Pharmacogenomics Market, by Disease Area
  1. By Cancer
  2. By Cardiovascular
  3. By Neurological Diseases
  4. By Other Disease Areas
7. Middle East & Africa Pharmacogenomics Market, by End User
  1. By Academic & Research Institutes
  2. By Pharmaceutical & Biotechnology Companies
  3. By Contract Research Organizations
8. Middle East & Africa Pharmacogenomics Market, by Country
  1. GCC Countries
    1. GCC Countries Pharmacogenomics Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. GCC Countries Pharmacogenomics Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. GCC Countries Pharmacogenomics Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. GCC Countries Pharmacogenomics Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. GCC Countries Pharmacogenomics Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
  2. South Africa
    1. South Africa Pharmacogenomics Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. South Africa Pharmacogenomics Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. South Africa Pharmacogenomics Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. South Africa Pharmacogenomics Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. South Africa Pharmacogenomics Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
  3. Rest of Middle East & Africa
    1. Rest of Middle East & Africa Pharmacogenomics Market, By Product & Service
      1. By Kits & Reagent
      2. By Service
    2. Rest of Middle East & Africa Pharmacogenomics Market, By Technology
      1. By Sequencing
      2. By PCR
      3. By Microarray
      4. By Other Technologies
    3. Rest of Middle East & Africa Pharmacogenomics Market, By Application
      1. By Personalized Medicine
      2. By Clinical Research
      3. By Drug Discovery & Preclinical Development
    4. Rest of Middle East & Africa Pharmacogenomics Market, By Disease Area
      1. By Cancer
      2. By Cardiovascular
      3. By Neurological Diseases
      4. By Other Disease Areas
    5. Rest of Middle East & Africa Pharmacogenomics Market, By End User
      1. By Academic & Research Institutes
      2. By Pharmaceutical & Biotechnology Companies
      3. By Contract Research Organizations
Key Market Dynamics
1. Introduction
2. Market Drivers
3. Market Restraints
4. Market Opportunities
5. Porter's Five Forces Analysis
6. PEST Analysis
7. Regulatory Landscape
8. Technology Landscape
9. Regional Market Trends
COVID 19 Impact Analysis
1. Key strategies undertaken by companies to tackle COVID-19
2. Short term dynamics
3. Long term dynamics
Marketing Stratagy Analysis
1. Marketing Channel
2. Direct Marketing
3. Indirect Marketing
4. Marketing Channel Development Trends
Competative Landscape
1. Competition Matrix - 2021
2. Company Market Share Analysis - 2021
3. Key Company Activities, 2018 - 2021
4. Strategic Developments - Heat Map Analysis
5. Company Offering Evaluation
6. Company Regional Presence Evaluation
Company Profiles
1. Illumina Inc. (U.S.)
2. Thermo Fisher Scientific Inc. (U.S.)
3. Danaher Corporation (U.S.)
4. Laboratory Corporation of America Holdings (U.S.)
5. Charles River Laboratories (U.S.)
6. Eurofins Scientific (Luxembourg)
7. Bio-Rad Laboratories Inc. (U.S.)
8. Agilent Technologies Inc. (U.S.)
9. Becton Dickinson and Company (U.S.)
10. QIAGEN (Germany)
11. F. Hoffmann-La Roche Ltd. (Switzerland)
12. Revvity (U.S.)
13. IQVIA Inc. (U.S.)
14. Mesa Labs Inc. (U.S.)
15. Medpace (U.S.)
16. MGI Tech Co. Ltd. (China)
17. Takara Bio Inc. (U.S.)
18. PacBio (U.S.)
19. New England Biolabs (U.S.)
20. BGI Genomics (China)
21. Novogene Co. Ltd. (China)
22. Sophia Genetics (Switzerland)
23. Fios Genomics (UK)
24. Personalis Inc. (U.S.)
25. BioAI Health Inc. (U.S.)
26. NeoGenomics Laboratories (U.S.)
27. Macrogen Inc. (South Korea)
Key Primary Respondents - VERBATIM
Discussion Guide
Customization Offered
Annexure
List of Figures
List of Tables
List of Abbreviations

Vantage Market Research | 10-Apr-2024

Industry Leaders and Emerging Players Shaping the Pharmacogenomics Landscape

FAQ

Frequently Asked Question

What is the global demand for Pharmacogenomics in terms of revenue?

The global Pharmacogenomics valued at USD 3.35 Billion in 2023 and is expected to reach USD 8.11 Billion in 2032 growing at a CAGR of 10.3%.

Which are the prominent players in the market?

The prominent players in the market are Illumina Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Danaher Corporation (U.S.), Laboratory Corporation of America Holdings (U.S.), Charles River Laboratories (U.S.), Eurofins Scientific (Luxembourg), Bio-Rad Laboratories Inc. (U.S.), Agilent Technologies Inc. (U.S.), Becton Dickinson and Company (U.S.), QIAGEN (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity (U.S.), IQVIA Inc. (U.S.), Mesa Labs Inc. (U.S.), Medpace (U.S.), MGI Tech Co. Ltd. (China), Takara Bio Inc. (U.S.), PacBio (U.S.), New England Biolabs (U.S.), BGI Genomics (China), Novogene Co. Ltd. (China), Sophia Genetics (Switzerland), Fios Genomics (UK), Personalis Inc. (U.S.), BioAI Health Inc. (U.S.), NeoGenomics Laboratories (U.S.), Macrogen Inc. (South Korea).

At what CAGR is the market projected to grow within the forecast period?

The market is project to grow at a CAGR of 10.3% between 2024 and 2032.

What are the driving factors fueling the growth of the market.

The driving factors of the Pharmacogenomics include
- The growing prevalence of chronic and genetic diseases is a significant driver propelling the pharmacogenomics market

Which region accounted for the largest share in the market?

North America was the leading regional segment of the Pharmacogenomics in 2023.

Pharmacogenomics Market

Pharmacogenomics Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Pharmacogenomics in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Quick Links

For Buying Inquiry

Pharmacogenomics Market

Pharmacogenomics Market - Global Industry Assessment & Forecast

Healthcare

Segments Covered

Snapshot

Customization Offered

FAQ

Frequently Asked Question

What is the global demand for Pharmacogenomics in terms of revenue?

Which are the prominent players in the market?

At what CAGR is the market projected to grow within the forecast period?

What are the driving factors fueling the growth of the market.

Which region accounted for the largest share in the market?

Related Reports

Request Sample Report for Pharmacogenomics Market

Vantage Point Interactive Dashboard